A Study of Pembrolizumab for Patients With Thymic Epithelial Tumor

Clinical trial NCT02607631 · COMPLETED

Trial details

NCT number: NCT02607631
Sponsor: Samsung Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Thymic Epithelial Tumors

Start date: 2015-11-01
Primary completion: 2018-02-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.